These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 35436288)
1. Prognostic Epstein-Barr Virus (EBV) miRNA biomarkers for survival outcome in EBV-associated epithelial malignancies: Systematic review and meta-analysis. Abusalah MAH; Irekeola AA; Hanim Shueb R; Jarrar M; Yean Yean C PLoS One; 2022; 17(4):e0266893. PubMed ID: 35436288 [TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-encoded microRNA BART22 serves as novel biomarkers and drives malignant transformation of nasopharyngeal carcinoma. Zhang T; Chen Z; Deng J; Xu K; Che D; Lin J; Jiang P; Gu X; Xu B Cell Death Dis; 2022 Jul; 13(7):664. PubMed ID: 35907914 [TBL] [Abstract][Full Text] [Related]
3. A Clinical Update on the Prognostic Effect of microRNA Biomarkers for Survival Outcome in Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis. Shaw P; Senthilnathan R; Krishnan S; Suresh D; Shetty S; Muthukaliannan GK; Mani RR; Sivanandy P; Chandramoorthy HCK; Gupta MM; Baxi S; Jayaraj R Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503179 [No Abstract] [Full Text] [Related]
4. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues. Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189 [TBL] [Abstract][Full Text] [Related]
5. Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV-infections. Ramayanti O; Verkuijlen SAWM; Novianti P; Scheepbouwer C; Misovic B; Koppers-Lalic D; van Weering J; Beckers L; Adham M; Martorelli D; Middeldorp JM; Pegtel DM Int J Cancer; 2019 May; 144(10):2555-2566. PubMed ID: 30411781 [TBL] [Abstract][Full Text] [Related]
6. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways. Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559 [TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus microRNA miR-BART2-5p accelerates nasopharyngeal carcinoma metastasis by suppressing RNase Ⅲ endonuclease DICER1. Wu Y; Zhang X; Liu C; Li Z; Wen Y; Zheng R; Xu C; Tian J; Wei L; Wang J; Yan Q; Zheng X; Ma J J Biol Chem; 2023 Sep; 299(9):105082. PubMed ID: 37495108 [TBL] [Abstract][Full Text] [Related]
8. Systematic review and meta-analysis of prognostic microRNA biomarkers for survival outcome in nasopharyngeal carcinoma. Sabarimurugan S; Kumarasamy C; Baxi S; Devi A; Jayaraj R PLoS One; 2019; 14(2):e0209760. PubMed ID: 30735523 [TBL] [Abstract][Full Text] [Related]
9. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment. Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622 [TBL] [Abstract][Full Text] [Related]
10. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma. Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of Epstein-Barr virus DNA level for nasopharyngeal carcinoma: a meta-analysis of 8128 cases. Qu H; Huang Y; Zhao S; Zhou Y; Lv W Eur Arch Otorhinolaryngol; 2020 Jan; 277(1):9-18. PubMed ID: 31659449 [TBL] [Abstract][Full Text] [Related]
12. Biomarkers predicting clinical outcomes in nasopharyngeal cancer patients receiving immune checkpoint inhibitors: A systematic review and meta-analysis. Qian X; Chen H; Tao Y Front Immunol; 2023; 14():1146898. PubMed ID: 37063822 [TBL] [Abstract][Full Text] [Related]
13. Clustered microRNAs of the Epstein-Barr virus cooperatively downregulate an epithelial cell-specific metastasis suppressor. Kanda T; Miyata M; Kano M; Kondo S; Yoshizaki T; Iizasa H J Virol; 2015 Mar; 89(5):2684-97. PubMed ID: 25520514 [TBL] [Abstract][Full Text] [Related]
14. Plasma Epstein-Barr Virus MicroRNA BART8-3p as a Diagnostic and Prognostic Biomarker in Nasopharyngeal Carcinoma. Lin C; Lin K; Zhang B; Su Y; Guo Q; Lu T; Xu Y; Lin S; Zong J; Pan J Oncologist; 2022 Apr; 27(4):e340-e349. PubMed ID: 35380720 [TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma. Zheng XH; Lu LX; Cui C; Chen MY; Li XZ; Jia WH Oncotarget; 2016 Jan; 7(4):4972-80. PubMed ID: 26701721 [TBL] [Abstract][Full Text] [Related]
16. Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma. Lu T; Guo Q; Lin K; Chen H; Chen Y; Xu Y; Lin C; Su Y; Chen Y; Chen M; Zheng Y; Ye Y; Lin S; Zong J; Pan J Cancer Sci; 2020 May; 111(5):1711-1723. PubMed ID: 32155300 [TBL] [Abstract][Full Text] [Related]
17. Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. Chen SJ; Chen GH; Chen YH; Liu CY; Chang KP; Chang YS; Chen HC PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862214 [TBL] [Abstract][Full Text] [Related]
18. Prognostic role of plasma Epstein-Barr virus DNA load for nasopharyngeal carcinoma: a meta-analysis. Liu TB; Zheng ZH; Pan J; Pan LL; Chen LH Clin Invest Med; 2017 Feb; 40(1):E1-E12. PubMed ID: 28218577 [TBL] [Abstract][Full Text] [Related]
19. A single nucleotide polymorphism in the BART promoter region of Epstein-Barr virus isolated from nasopharyngeal cancer cells. Kim H; Burassakarn A; Kang Y; Iizasa H; Yoshiyama H Biochem Biophys Res Commun; 2019 Dec; 520(2):373-378. PubMed ID: 31606205 [TBL] [Abstract][Full Text] [Related]
20. BART-D2 subtype of EBV encoded BART miRNA cluster 1 region is strongly associated with endemic nasopharyngeal carcinoma. Wang Q; He H; Ji X; Liu Y; Li H; Wang Y J Med Virol; 2023 Mar; 95(3):e28667. PubMed ID: 36912378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]